(Q29543246)

22 April 2017

1 reference

Nick X. Wang

1

1 reference

22 April 2017

Horst A. von Recum

series ordinal

2

1 reference

22 April 2017

publication date

24 November 2010

1 reference

Macromolecular Bioscience

22 April 2017

published in

1 reference

22 April 2017

volume

11

1 reference

22 April 2017

issue

3

1 reference

22 April 2017

page(s)

321-332

1 reference

The origins and evolution of "controlled" drug delivery systems

22 April 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Controlled delivery of peptides and proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Efficient siRNA delivery with non-viral polymeric vehicles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Recent trends in non-viral vector-mediated gene delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Hydrogels in controlled release formulations: network design and mathematical modeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Mathematical modeling and simulation of drug release from microspheres: Implications to drug delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Stimulus-controlled delivery of drugs and genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Stimuli responsive polymers for biomedical applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Affinity chromatography: general methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Engineered affinity proteins for tumour-targeting applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Physicochemical foundations and structural design of hydrogels in medicine and biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Modeling of drug release from swellable polymers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Mathematical modeling of bioerodible, polymeric drug delivery systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Biodegradable polymers for ocular drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Hydrophilic molecularly imprinted poly(hydroxyethyl-methacrylate) polymers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Recent advances on noncovalent molecular imprints for affinity separations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Soft contact lenses capable of sustained delivery of timolol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Molecularly imprinted materials as advanced excipients for drug delivery systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Recent developments in the molecular imprinting of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Molecularly imprinted polymers for the recognition of proteins: the state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Molecular imprinting of proteins emerging as a tool for protein recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Drug assay using antibody mimics made by molecular imprinting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Approaches to molecular imprinting based selectivity in capillary electrochromatography

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Molecularly imprinted polymer as a solid phase extractor in flow analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Stimuli-responsive molecularly imprinted polymers for drug delivery: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Development of a reservoir-type transdermal enantioselective-controlled delivery system for racemic propranolol using a molecularly imprinted polymer composite membrane

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Molecularly imprinted polymers for drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Enantioselective release of controlled delivery granules based on molecularly imprinted polymers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Recognition properties and competitive assays of a dual dopamine/serotonin selective molecularly imprinted polymer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Stereoselective release behaviors of imprinted bead matrices

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Use of molecularly imprinted polymers from a mixture of tetracycline and its degradation products to produce affinity membranes for the removal of tetracycline from water

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Molecularly imprinted polymers for the enantioseparation of chiral drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

The nature of backbone monomers determines the performance of imprinted soft contact lenses as timolol drug delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Timolol uptake and release by imprinted soft contact lenses made of N,N-diethylacrylamide and methacrylic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Ocular release of timolol from molecularly imprinted soft contact lenses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Imprinted soft contact lenses as norfloxacin delivery systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Controlling drug release from imprinted hydrogels by modifying the characteristics of the imprinted cavities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Transport and structural analysis of molecular imprinted hydrogels for controlled drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Biomimetic hydrogels for enhanced loading and extended release of ocular therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Preliminary evaluation of molecular imprinting of 5-fluorouracil within hydrogels for use as drug delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Spherical molecularly imprinted polymers (SMIPs) via a novel precipitation polymerization in the controlled delivery of sulfasalazine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Controlled release of high molecular weight hyaluronic Acid from molecularly imprinted hydrogel contact lenses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Rational design of low-molecular weight heparins with improved in vivo activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Development of rationally designed affinity-based drug delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Development of fibrin derivatives for controlled release of heparin-binding growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Controlled and modulated release of basic fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Isolation of brain fibroblast growth factor by heparin-Sepharose affinity chromatography: identity with pituitary fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Controlled release of nerve growth factor from a heparin-containing fibrin-based cell ingrowth matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

PDGF-BB released in tendon repair using a novel delivery system promotes cell proliferation and collagen remodeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Controlled release of glial-derived neurotrophic factor from fibrin matrices containing an affinity-based delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Affinity-based release of glial-derived neurotrophic factor from fibrin matrices enhances sciatic nerve regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Rheological characterization of polysaccharide-poly(ethylene glycol) star copolymer hydrogels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Production of heparin-functionalized hydrogels for the development of responsive and controlled growth factor delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Growth factor mediated assembly of cell receptor-responsive hydrogels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Binding and release of basic fibroblast growth factor from heparinized collagen matrices

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

The impact of proteinase-induced matrix degradation on the release of VEGF from heparinized collagen matrices

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Heparin-modified dendrimer cross-linked collagen matrices for the delivery of basic fibroblast growth factor (FGF-2).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Loading of VEGF to the heparin cross-linked demineralized bone matrix improves vascularization of the scaffold.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Crosslinking heparin to collagen scaffolds for the delivery of human platelet-derived growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Sustained release of basic fibroblast growth factor and angiogenesis in a novel covalently crosslinked gel of heparin and alginate

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Novel heparin/alginate gel combined with basic fibroblast growth factor promotes nerve regeneration in rat sciatic nerve

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Injectable glycosaminoglycan hydrogels for controlled release of human basic fibroblast growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Formation of a novel heparin-based hydrogel in the presence of heparin-binding biomolecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Heparin functionalized PEG gels that modulate protein adsorption for hMSC adhesion and differentiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Rationally designed peptides for controlled release of nerve growth factor from fibrin matrices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

The effect of sulfation of alginate hydrogels on the specific binding and controlled release of heparin-binding proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

The effects of controlled HGF delivery from an affinity-binding alginate biomaterial on angiogenesis and blood perfusion in a hindlimb ischemia model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Mechanisms by which cyclodextrins modify drug release from polymeric drug delivery systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Cyclodextrins: their future in drug formulation and delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Pharmaceutical applications of cyclodextrins. 2. In vivo drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Drug/cyclodextrin/hydroxy acid multicomponent systems. Properties and pharmaceutical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Cyclodextrin complexes of salts of acidic drugs. Thermodynamic properties, structural features, and pharmaceutical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Cyclodextrins and their pharmaceutical applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Cyclodextrins in drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Drug-binding hydrogels of hyaluronic acid functionalized with beta-cyclodextrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Cyclodextrin-based device coatings for affinity-based release of antibiotics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Cyclodextrin complexation for affinity-based antibiotic delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Vascular prostheses with controlled release of antibiotics Part 1: Surface modification with cyclodextrins of PET prostheses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Vascular prostheses with controlled release of antibiotics Part 2. In vitro biological evaluation of vascular prostheses treated by cyclodextrins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Vascular PET prostheses surface modification with cyclodextrin coating: development of a new drug delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Prolonged local antibiotics delivery from hydroxyapatite functionalised with cyclodextrin polymers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Cyclodextrin/PEG based hydrogels for multi-drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Cyclodextrin/carbopol micro-scale interpenetrating networks (ms-IPNs) for drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

New cyclodextrin hydrogels cross-linked with diglycidylethers with a high drug loading and controlled release ability

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Improved drug delivery properties of PVDF membranes functionalized with beta-cyclodextrin--application to guided tissue regeneration in periodontology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Acrylic/cyclodextrin hydrogels with enhanced drug loading and sustained release capability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Predicting the free energies of complexation between cyclodextrins and guest molecules: linear versus nonlinear models.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Use of beta-cyclodextrins to prevent modifications of the properties of carbopol hydrogels due to carbopol-drug interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Pullulan-cyclodextrin microspheres. A chromatographic approach for the evaluation of the drug-cyclodextrin interactions and the determination of the drug release profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Poly(hydroxyethyl methacrylate-co-methacrylated-beta-cyclodextrin) hydrogels: synthesis, cytocompatibility, mechanical properties and drug loading/release properties.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Cationic polymer based gene delivery systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Polycation-mediated delivery of siRNAs for prophylaxis and treatment of influenza virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Non-viral gene therapy: polycation-mediated DNA delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Polycation gene delivery systems: escape from endosomes to cytosol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Efficient gene delivery using chitosan-polyethylenimine hybrid systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Delivery of RNA interference therapeutics using polycation-based nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Polycation-based nanoparticle delivery for improved RNA interference therapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Barriers to gene delivery using synthetic vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Development of non-viral vectors for systemic gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

The location of drug binding sites in human serum albumin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

Drug release from hydrogel containing albumin as crosslinker

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FMABI.201000206

21 January 2018

Identifiers

DOI

10.1002/MABI.201000206

1 reference